Brought to you by 
Auxilium Pharmaceuticals nets $43.3mm with private financing
26 Sep 2006
Executive Summary
Auxilium Pharmaceuticals (developing therapeutics to for sexual health and urological conditions) has netted $43.3mm with the private placement of 5.5mm common shares priced at $8.50 each (a 9% discount). Selected institutional investors, including Atlas Ventures, Visium Capital Management, Balyasny Asset Management, and a private backer participated. Thomas Weisel Partners and Roth Capital Partners acted as placement agents for the transaction.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Topical Delivery
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Auxilium Pharmaceuticals nets $43.3mm with private financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice